ClassID:

109598

C12N2710/00034 - CPC Classification

Classification description:

dsDNA viruses; Details Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Recent Application in this class:
#1
20260021174
2026-01-22

CULTURE METHOD FOR FISH CELLS AND CELL CULTURE MEDIUM USED THEREIN, AND ORAL VACCINE FOR FISH

#2
20250213677
2025-07-03

DRUG-DELIVERY COMPOSITION INCLUDING PLANT-DERIVED NANOVESICLES AS ACTIVE INGREDIENTS

#3
20250152700
2025-05-15

ALUMINUM NANOCRYSTAL DELIVERY SYSTEM, AND SELF-ASSEMBLED PARTICLE ADJUVANT VACCINE BASED ON BINDING OF ALUMINUM NANOCRYSTAL DELIVERY SYSTEM AND VACCINE ANTIGEN MOLECULE

#4
20250127886
2025-04-24

ASSESSMENT AND TREATMENT OF CHRONIC HEPATITIS B

#5
20240398937
2024-12-05

PSEUDORABIES VIRUS (PRV) EXPRESSING PORCINE CIRCOVIRUS 2 (PCV2) CAPSID PROTEIN ON ENVELOPE AND USE THEREOF

#6
20220056080
2022-02-24

Muramyl peptide derivatives

#7
20210260184
2021-08-26

MULTIVALENT CMV VACCINE AND USES THEREOF

#8
20200376111
2020-12-03

VACCINE COMPOSITION

#9
20200316194
2020-10-08

Treatment of infection

#10
20180371023
2018-12-27

Muramyl peptide derivative compound, synthesis and uses thereof

#11
20180360957
2018-12-20

Muramyl peptide derivative compound, synthesis and uses thereof

#12
20180353601
2018-12-13

Treatment of infection

#13
20180311339
2018-11-01

Compositions and methods for the treatment or prevention of hepatitis B virus infection

#14
20180080047
2018-03-22

Promoters

#15
20180002382
2018-01-04

Polypeptides and antibodies for treating HBV infection and related diseases

#16
20170281691
2017-10-05

Methods for constructing antibiotic resistance free vaccines

#17
20170173148
2017-06-22

Treatment of infection

#18
20170028045
2017-02-02

Methods for constructing antibiotic resistance free vaccines

#19
20170021014
2017-01-26

VACCINE ADJUVANTS FOR CYTOMEGALOVIRUS PREVENTION AND TREATMENT

#20
20170000879
2017-01-05

Compositions and methods for the treatment or prevention of hepatitis B virus infection

#21
20160279236
2016-09-29

USE OF RAPAMYCIN AS VACCINE ADJUVANT AND PREPARATION METHOD THEREFOR

#22
20150246948
2015-09-03

Polypeptides and antibodies for treating HBV infection and related diseases

#23
20150004194
2015-01-01

Facilitator-DNA combination vaccine

#24
20140370049
2014-12-18

Method for formulating a vaccine containing at least two antigens capable of adsorbing onto aluminium oxyhydroxide

#25
20130266612
2013-10-10

Vaccine composition

#26
20120058149
2012-03-08

TREATMENT OF INFECTION

#27
20100316663
2010-12-16

Subunit vaccine for aquaculture

#28
20060104991
2006-05-18

Methods for constructing antibiotic resistance free vaccines

#29
20060013828
2006-01-19

Immunizing fish against viral infection

#30
18938932
2025-11-18

3 (MDV-2), a viral vector against different avian pathogens: a new vaccination strategy in the poultry industry